pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,281 catalysts · 3,150 8k filing · 2,029 grant · 1,000 device adverse event · 897 approval · 659 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 43 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-30×clear all
type
  • 8k filing3,150
  • grant2,029
  • device adverse event1,000
  • approval897
  • device 510k659
  • earnings584
  • device pma503
  • device recall211
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 26, 2026

    25
    ›Feb 1, 2026grant193d agoVANDERBILT UNIVERSITY — Understanding sphingolipid-dependent remodeling of mitochondria in aging cells

    AG grant. $482,800. PI: Kristopher Burkewitz

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF RHODE ISLAND — Tissue-Specific Modulation of mtDNA Mutations: Exploring Aging and Lifestyle ...

    AG grant. $567,224. PI: Giuseppe Coppotelli

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF NEBRASKA MEDICAL CENTER — Next Generation Treatment of PAD

    AG grant. $644,298. PI: Panagiotis Koutakis

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Aging Impairs Wound Healing by an HSC-Autonomous Mechanism

    AG grant. $626,409. PI: Louis Michael Messina

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoPRINCETON UNIVERSITY — Leveraging Ecological Interactions to Unearth Cryptic Metabolites and Regulat...

    GM grant. $137,484. PI: John Ganley

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF COLORADO DENVER — Investigating IgA regulation of Candida glabrata within the intestinal microb...University of Colorado Denver

    AI grant. $412,422. PI: Kyla Ost

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoTEXAS TECH UNIVERSITY — miRNA-Driven Mitochondrial Dysfunction in Alzheimer’s Disease

    AG grant. $447,541. PI: Murali Vijayan

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoCORNELL UNIVERSITY — Epigenetic Aging: The Impact of Social and Environmental Realism

    AG grant. $458,871. PI: Michael J Sheehan

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoSTANFORD UNIVERSITY — A Novel Imaging Strategy to Optimize Brain Tumor ImmunotherapyStanford University

    NS grant. $499,516. PI: Corinne Beinat

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF VIRGINIA — Investigating the role of Cd59 in oligodendrocyte developmentUniversity of Virginia

    NS grant. $42,834. PI: Veronica Coyle

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF CALIFORNIA-IRVINE — Longitudinal relationships between Alzheimer's disease pathophysiology, local...Metallomix Inc

    AG grant. $619,099. PI: BRYCE A. MANDER

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF COLORADO DENVER — Development and Characterization of the MAIT-Boost Knock-In (MBKI) Mouse to I...University of Colorado Denver

    AI grant. $429,000. PI: Laurent Gapin

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Novel Machine Learning Methods for Immunosenescence and Aging Research

    AG grant. $298,419. PI: Gen Li

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoLA JOLLA INSTITUTE FOR IMMUNOLOGY — Illuminating Immunoregulatory Mechanisms of Interleukin-1 Receptor 8 and Nove...Dawn Sea Therapeutics

    AI grant. $890,877. PI: Haoyang Li

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoWASHINGTON UNIVERSITY — Brown adipose tissue derived nidogen-2 as a diabetes therapeutic

    DK grant. $578,846. PI: David W Piston

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF PENNSYLVANIA — Acetyl-CoA metabolism and the regulation of hepatic lipid homeostasis in MASLDUniversity of Pennsylvania

    DK grant. $892,491. PI: Christian Michael Metallo

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoCOLD SPRING HARBOR LABORATORY — CSHL 2026 Protein Homeostasis in Health & Disease Conference

    AG grant. $33,900. PI: DAVID J. STEWART

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Skeletal Muscle Stem Cells and RegenerationUniversity of California Los Angeles

    AR grant. $42,500. PI: April D Pyle

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoJOHNS HOPKINS UNIVERSITY — Natural Language Processing Phenotyping of Spirituality and Resilience Among ...Johns Hopkins University

    DA grant. $75,600. PI: Suky Martinez

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoCASE WESTERN RESERVE UNIVERSITY — Nigeria HIV Research Training ProgramCase Western Reserve University

    TW grant. $270,261. PI: Ighovwerha Ofotokun

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Technologies to probe the biophysical properties of aging cellsNew York University

    AG grant. $708,137. PI: Liam J Holt

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF WISCONSIN-MADISON — Molecular Mechanisms of Fiber Type-Specific Skeletal Muscle Dysfunction with ...

    AG grant. $698,690. PI: Jesse Meyer

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoUNIVERSITY OF MISSOURI-COLUMBIA — Investigating the role of the gut-brain axis in Alzheimer's Disease mitigatio...Metallomix Inc

    AG grant. $676,608. PI: Priti Balchandani

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoYALE UNIVERSITY — Translational studies of hookworm infection in Ghana

    AI grant. $84,829. PI: MICHAEL CAPPELLO

    full page →nih reporter ↗
    ›Feb 1, 2026grant193d agoYALE UNIVERSITY — Engineering and targeting the sperm-specific calcium channel CatSper for cont...

    HD grant. $787,586. PI: Jean-Ju Lucia Chung

    full page →nih reporter ↗

    Week of Feb 2, 2026

    25
    ›Feb 2, 2026approval192d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval
    ← prev
    page 6 of 186
    next →
    192d ago
    CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoMETHYLENE BLUE — FDA approvalMETHYLENE BLUE

    Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS

    full page →METHYLENE BLUE →fda approvals ↗
    ›Feb 2, 2026approval192d agoTYRUKO (NATALIZUMAB-SZTN) — FDA approvalnatalizumab biosimilar

    Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

    full page →natalizumab biosimilar →fda approvals ↗
    ›Feb 2, 2026approval192d agoLENALIDOMIDE — FDA approvalLENALIDOMIDE

    Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

    full page →LENALIDOMIDE →fda approvals ↗
    ›Feb 2, 2026approval192d agoPRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalprimaquine phosphate

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →primaquine phosphate →fda approvals ↗
    ›Feb 2, 2026approval192d agoNORLIQVA (AMLODIPINE BESYLATE) — FDA approvalChina Resources Saike Pharmaceutical Co Ltd

    Sponsor: CMP DEV LLC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoAIR — FDA approval

    Sponsor: GENERAL AIR SERVICE & SUPPLY COMPANY. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoPUR-WASH (PURIFIED WATER) — FDA approval

    Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoFIDAXOMICIN — FDA approvalDificid

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →Dificid →fda approvals ↗
    ›Feb 2, 2026approval192d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 2, 2026approval192d agoMIRTAZAPINE — FDA approvalmirtazapine ODT

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →mirtazapine ODT →fda approvals ↗
    ›Feb 2, 2026approval192d agoESTRADIOL — FDA approvalLong Grove Pharmaceuticals LLC

    Sponsor: LONG GROVE PHARMS. Form: GEL, METERED. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval192d agoPREGABALIN — FDA approvalViatris Inc

    Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026device 510k192d agoNano-X Imaging , Ltd. — TAP2D (510k cleared)Nano-X Imaging Ltd.

    Product code: IZF. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k192d agoChengdu Besmile Medical Technology Co., Ltd. — BIORES Dental Implant System (510k cleared)

    Product code: DZE. Advisory committee: Dental. Type: Abbreviated

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k192d agoOxehealth Limited — Vital Signs (510k cleared)

    Product code: QME. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k192d agoBeijing Kreate Medical Co., Ltd. — Redermax Antibacterial Wound Matrix (510k cleared)

    Product code: FRO. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k192d agoAsahi Intecc Co., Ltd. — CHIKAI Nexus petit (510k cleared)

    Product code: MOF. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device pma192d agoPhilips Medical Systems, Inc. — HeartStart OnSite Defibrillator (Model M5066A) and HeartStart Home Defibrillator (Model M5068A) (PMA supplement)MERIT MEDICAL SYSTEMS INC

    Supplement type: 30-Day Notice. Product code: NSA. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma192d agoCooperVision, Inc. — Biofmity XR Torie (comfilcon A) Soft (Hydrophilic) Contact Lenses for Extended Wear (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma192d agoEdwards Lifesciences, LLC — Edwards EVOQUE Tricuspid Valve Replacement System (PMA supplement)Edwards Lifesciences Corp

    Supplement type: 30-Day Notice. Product code: NPW. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma192d agoPhilips Medical Systems — HeartStart FRx Defibrillator (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MKJ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device recall192d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

    Brand Name: B. Braun Product Name: 21GA WINGED INF SET Model/Catalog Number: 7M2802 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

    full page →fda device recalls ↗
    $MMSI91.11+1.52%
    $NNOX1.7300+1.17%
    $VTRS16.280.00%
    $EW91.33-2.47%